Our multi-disciplinary team, led on the neurological side by a consultant neurologist and on the transplant side by our haematology team, assesses: A confirmed diagnosis of generalised myasthenia gravis Severe disease that remains uncontrolled, or controllable only at an unacceptable cost, despite the full conventional ladder including steroids, steroid-sparing agents, rituximab where indicated, thymectomy where indicated, and the newer biologics A pattern of repeated crises or heavy dependence on rescue therapy Adequate heart, lung, liver and kidney function, and general fitness for the procedure, with careful assessment of respiratory reserve A patient whose MG is well controlled on standard treatment is not a candidate, and we will say so
Ther Adv Respir Dis
Open communication about sexual changes during semaglutide treatment is essential
But yeah, so the thing about the studies on these, so the GLP-1s, those clinical trials are expanding